Can an ‘Under the Radar’ Drugmaker Shake Off Bears With New Data?

(Bloomberg) -- Galmed Pharmaceuticals Ltd. has never closed above $350 million in market value, while peers developing similar therapies for liver disease and trailing behind the company in their d...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.